{"schema_version":"secwatch.filing_event.v1","accession":"0001087294-25-000017","form_type":"8-K","ticker":"CPIX","cik":"0001087294","company_name":"CUMBERLAND PHARMACEUTICALS INC","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.763307+00:00","generated_at":"2026-05-17T00:32:15.947634+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cumberland Pharma reports Q3 net loss of $1.9M; YTD revenue up 12% to $30.8M","bullets":["Net revenue for Q3 2025 was $8.3M; YTD $30.8M (+12% vs. 2024).","Net loss Q3 $1.9M; YTD net loss $1.4M. Adjusted loss Q3 $0.8M ($0.06/sh); adjusted earnings YTD $1.9M ($0.13/sh).","Added Talicia via joint venture with RedHill: Cumberland invests $4M for 30% ownership; net revenue split equally.","Vibativ launched in Saudi Arabia; ibuprofen injection approved in Mexico; Vibativ available through Vizient.","Ifetroban Phase II DMD showed 5.4% cardiac improvement; Phase II SSc enrollment complete; IPF trial enrolling."],"urls":{"canonical":"https://secwatch.observer/filing/0001087294-25-000017","json":"https://secwatch.observer/filing/0001087294-25-000017.json","markdown":"https://secwatch.observer/filing/0001087294-25-000017.md","text":"https://secwatch.observer/filing/0001087294-25-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000017/0001087294-25-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000017/cpix-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:32:15.947634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}